New proposed definitions integrate biomarkers of structural injury to the kidney which may be able to differentiate more accurately AKI and CKD in populations without known kidney function prior to infection (e.g., urine neutrophil gelatinase-associated lipocalin (NGAL), also known as lipocalin-2 [72]). The gene discussed is LCN2; the disease is chronic kidney disease.